BIONUMERIK Trademark

Trademark Overview


On Thursday, March 24, 2005, a trademark application was filed for BIONUMERIK with the United States Patent and Trademark Office. The USPTO has given the BIONUMERIK trademark a serial number of 78593946. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 3, 2016. This trademark is owned by BioNumerik Pharmaceuticals, Inc.. The BIONUMERIK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the following diseases and medical conditions; cancer; sickle cell anemia; the toxicity of side-effects of chemotherapeutic treatment; neurotoxicity; adult respiratory distress syndrome; acute renal failure treatment; septic shock or shock/ischemia; ethanol-induced physiological symptoms ("Hang-over"); ethylene glycol poisoning; radiation exposure; osteoporosis; cardiomyopathy; diabetic neuropathy; diabetic opthalmopathy; diabetic angiopathy; diabetic nephropathy; hypertension; atherosclerosis and peripheral vascular disease; ischemia; gastrointestinal distress; patients exposed to toxic chemicals; heavy metal poisoning or exposure; complications arising from AIDS; alcoholism and complications arising therefrom; acetaminophen overdosage; the renal calculi (kidney stones); inhibiting angiogenesis; Wilson's disease; Treatment for reducing toxicity associated with diabetes treatments; inflammatory bowel disorder; complication arising from tobacco smoke exposure...
bionumerik

General Information


Serial Number78593946
Word MarkBIONUMERIK
Filing DateThursday, March 24, 2005
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 3, 2016
Registration Number3703574
Registration DateTuesday, October 27, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2006

Trademark Statements


Goods and ServicesPharmaceutical products for the following diseases and medical conditions; cancer; sickle cell anemia; the toxicity of side-effects of chemotherapeutic treatment; neurotoxicity; adult respiratory distress syndrome; acute renal failure treatment; septic shock or shock/ischemia; ethanol-induced physiological symptoms ("Hang-over"); ethylene glycol poisoning; radiation exposure; osteoporosis; cardiomyopathy; diabetic neuropathy; diabetic opthalmopathy; diabetic angiopathy; diabetic nephropathy; hypertension; atherosclerosis and peripheral vascular disease; ischemia; gastrointestinal distress; patients exposed to toxic chemicals; heavy metal poisoning or exposure; complications arising from AIDS; alcoholism and complications arising therefrom; acetaminophen overdosage; the renal calculi (kidney stones); inhibiting angiogenesis; Wilson's disease; Treatment for reducing toxicity associated with diabetes treatments; inflammatory bowel disorder; complication arising from tobacco smoke exposure; venomous snakebite; patients undergoing kidney dialysis or peritoneal dialysis; chemotherapy/drug extravasation injury; lymphedema; chemotherapy- or drug-induced toxicity; platinum or alkylating agent overdose; hyperbaric toxicity; chemotherapy- or radiation-induced mucositis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 3, 2016
Primary Code005
First Use Anywhere DateFriday, May 31, 1996
First Use In Commerce DateTuesday, September 30, 1997

Trademark Owner History


Party NameBioNumerik Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Antonio, TX 78229

Party NameBioNumerik Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Antonio, TX 78229

Party NameBioNumerik Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Antonio, TX 78229

Trademark Events


Event DateEvent Description
Friday, June 3, 2016CANCELLED SEC. 8 (6-YR)
Tuesday, October 27, 2009REGISTERED-PRINCIPAL REGISTER
Monday, September 21, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, September 21, 2009ASSIGNED TO LIE
Friday, September 11, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 24, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 24, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 24, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 6, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 6, 2009NON-FINAL ACTION E-MAILED
Thursday, August 6, 2009SU - NON-FINAL ACTION - WRITTEN
Friday, July 10, 2009STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 16, 2009USE AMENDMENT FILED
Friday, July 10, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 16, 2009TEAS STATEMENT OF USE RECEIVED
Friday, January 9, 2009EXTENSION 5 GRANTED
Friday, January 9, 2009EXTENSION 5 FILED
Friday, January 9, 2009TEAS EXTENSION RECEIVED
Tuesday, September 23, 2008EXTENSION 4 GRANTED
Tuesday, September 23, 2008EXTENSION 4 FILED
Tuesday, September 23, 2008TEAS EXTENSION RECEIVED
Tuesday, February 5, 2008ASSIGNED TO EXAMINER
Wednesday, January 9, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 8, 2007EXTENSION 3 GRANTED
Thursday, November 8, 2007EXTENSION 3 FILED
Thursday, November 8, 2007TEAS EXTENSION RECEIVED
Friday, September 14, 2007EXTENSION 2 GRANTED
Friday, September 14, 2007EXTENSION 2 FILED
Friday, September 14, 2007TEAS EXTENSION RECEIVED
Tuesday, April 10, 2007EXTENSION 1 GRANTED
Tuesday, April 10, 2007EXTENSION 1 FILED
Tuesday, April 10, 2007TEAS EXTENSION RECEIVED
Tuesday, October 17, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 25, 2006PUBLISHED FOR OPPOSITION
Wednesday, July 5, 2006NOTICE OF PUBLICATION
Friday, June 2, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 26, 2006ASSIGNED TO LIE
Friday, May 12, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 21, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 12, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 12, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 20, 2005NON-FINAL ACTION MAILED
Wednesday, October 19, 2005NON-FINAL ACTION WRITTEN
Wednesday, October 19, 2005ASSIGNED TO EXAMINER
Tuesday, March 29, 2005NEW APPLICATION ENTERED IN TRAM